New guidelines on the diagnosis and management of aortic disease have been published by the American College of Cardiology and the American Heart Association. These guidelines aim to guide clinicians to make informed decisions in the diagnosis, genetic evaluation and family screening, medical therapy, endovascular and surgical treatment, and long-term…
In this VASCERN Exchange Program interview, we are thrilled to interview Dr. Maryanne Caruana from Mater Dei Hospital in Msida, Malta. Dr. Maryanne Caruana is a member of the Heritable Thoracic Aortic Disease (HTAD). In this article, she shares what her goals were for the exchange program, and the lessons…
What a great way to end the month of October with its slew of conferences, seminars and scientific meetings discussing new research outcomes and improvements in patient treatment and care. The EuroThrombosis and EuroVessels 2022 (ETEV) meeting was held in Lisbon, Portugal from 20 – 22 October 2022. This conference was attended by Prof. Julie De…
A new collaborative research paper titled Arrhythmia and impaired myocardial function in heritable thoracic aortic disease: An international retrospective cohort study has been published in VASCERN Special Issue of the European Journal of Medical Genetics. It is co-authored by members and affiliated partners of the VASCERN Heritable Thoracic Aortic Diseases…
